Tyr1 and Ile7 of Glucose-Dependent Insulinotropic Polypeptide (GIP) Confer Differential Ligand Selectivity toward GIP and Glucagon-like Peptide-1 Receptors

被引:16
作者
Moon, Mi Jin [1 ]
Kim, Hee Young [2 ]
Kim, Sin Gon [2 ]
Park, Juri [2 ]
Choi, Dong Seop [2 ]
Hwang, Jong-Ik [1 ]
Seong, Jae Young [1 ]
机构
[1] Korea Univ, Grad Sch Med, Seoul 136705, South Korea
[2] Korea Univ, Coll Med, Div Endocrinol & Metab, Dept Internal Med, Seoul 136705, South Korea
关键词
GIP; GLP-1; GPCR; ligand selectivity; insulin; pancreas; GASTRIC-INHIBITORY POLYPEPTIDE; MOLECULAR EVOLUTION; BIOACTIVE DOMAIN; GLP-1; EXENDIN-4; AGONIST; BIOLOGY; BINDING; GENE; CELL;
D O I
10.1007/s10059-010-0100-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glucagon like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are incretin hormones released in response to food intake and potentiate insulin secretion from pancreatic beta cells through their distinct yet related G protein-coupled receptors, GLP1R and GIPR. While GLP-1 and GIP exhibit similarity in their N-terminal sequence and overall alpha-helical structure, GLP-1 does not bind to GIPR and vice versa. To determine which amino acid residues of these peptide ligands are responsible for specific interaction with their respective receptors, we generated mutant GIP in which several GLP-1-specific amino acid residues were substituted for the original amino acids. The potency of the mutant ligands was examined using HEK293 cells transfected with GLP1R or GIPR expression plasmids together with a cAMP-responsive element-driven luciferase (CRE-luc) reporter plasmid. A mutated GIP peptide in which Tyr(1), Ile(7), Asp(15), and His(18) were replaced by His, Thr, Glu, and Ala, respectively, was able to activate both GLP1R and GIPR with moderate potency. Replacing the original Tyr(1) and/or Ile(7) in the N-terminal moiety of this mutant peptide allowed full activation of GIPR but not of GLP1R. However, reintroducing Asp(15) and/or His(18) in the central alpha-helical region did not significantly alter the ligand potency. These results suggest that Tyr/His(1) and Ile/Thr(7) of GIP/GLP-1 peptides confer differential ligand selectivity toward GIPR and GLP1R.
引用
收藏
页码:149 / 154
页数:6
相关论文
共 22 条
[1]  
ADELHORST K, 1994, J BIOL CHEM, V269, P6275
[2]   A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors [J].
Al-Sabah, S ;
Donnelly, D .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (02) :339-346
[3]   Biology of incretins: GLP-1 and GIP [J].
Baggio, Laurie L. ;
Drucker, Daniel J. .
GASTROENTEROLOGY, 2007, 132 (06) :2131-2157
[4]   Molecular evolution of neuropeptide receptors with regard to maintaining high affinity to their authentic ligands [J].
Cho, Hyun Ju ;
Acharjee, Suiata ;
Moon, Mi Jin ;
Oh, Da Young ;
Vaudry, Hubert ;
Kwon, Hyuk Bang ;
Seong, Jae Young .
GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2007, 153 (1-3) :98-107
[5]   GLUCAGONLIKE PEPTIDE-I STIMULATES INSULIN GENE-EXPRESSION AND INCREASES CYCLIC-AMP LEVELS IN A RAT ISLET CELL-LINE [J].
DRUCKER, DJ ;
PHILIPPE, J ;
MOJSOV, S ;
CHICK, WL ;
HABENER, JF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (10) :3434-3438
[6]   CELL AND MOLECULAR-BIOLOGY OF THE INCRETIN HORMONES GLUCAGON-LIKE PEPTIDE-I AND GLUCOSE-DEPENDENT INSULIN RELEASING POLYPEPTIDE [J].
FEHMANN, HC ;
GOKE, R ;
GOKE, B .
ENDOCRINE REVIEWS, 1995, 16 (03) :390-410
[7]   STRUCTURE/ACTIVITY CHARACTERIZATION OF GLUCAGON-LIKE PEPTIDE-1 [J].
GALLWITZ, B ;
WITT, M ;
PAETZOLD, G ;
MORYSWORTMANN, C ;
ZIMMERMANN, B ;
ECKART, K ;
FOLSCH, UR ;
SCHMIDT, WE .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 225 (03) :1151-1156
[8]   GLP-1/GIP chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1 [J].
Gallwitz, B ;
Witt, M ;
MorysWortmann, C ;
Folsch, UR ;
Schmidt, WE .
REGULATORY PEPTIDES, 1996, 63 (01) :17-22
[9]  
GOKE R, 1993, J BIOL CHEM, V268, P19650
[10]   In depth analysis of the N-terminal bioactive domain of gastric inhibitory polypeptide [J].
Hinke, SA ;
Manhart, S ;
Speck, M ;
Pederson, RA ;
Demuth, HU ;
McIntosh, CHS .
LIFE SCIENCES, 2004, 75 (15) :1857-1870